<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03481530</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00002113</org_study_id>
    <nct_id>NCT03481530</nct_id>
  </id_info>
  <brief_title>Role of CGMS Usage in Predicting Risk for Hypoglycemia</brief_title>
  <official_title>Development of Novel Predictors of Hypoglycemia for Type 2 Diabetes: Role of CGMS Usage in Predicting Risk for Hypoglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical study to examine rates hypoglycemia (self-report, EHR review, and review
      of values from a FDA approved continuous glucose monitoring system (CGMS)). Subjects will
      wear either blinded or unblinded CGMS. This is a 1:1 assignment with one group (50%) wearing
      1 unblinded/1 blinded CGMS and the other group 50% wearing 2 blinded CGMS. The assignment
      will be computer based in a random fashion. Participants will continue with their usual
      diabetes management and glycemic monitoring profile as per usual. Those assigned to an
      unblinded CGMS can use the CGMS to manage their glucose levels at their own discretion.
      Individuals recruited will be those Type 2 diabetes who are deemed to be at high risk for
      hypoglycemia or low risk for hypoglycemia from a point score system established in an
      affiliated study.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>One arm is blinded, one isn't.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hypoglycemia rate</measure>
    <time_frame>Week 16</time_frame>
    <description>Overall rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison hypoglycemia rate</measure>
    <time_frame>Week 16</time_frame>
    <description>Comparison between blinded and unblinded arms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>Blinded</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Continuing Glucose Monitoring System will be blinded</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unblinded</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Continuing Glucose Monitoring System will be open. Participant can review results if they choose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuing Glucose Monitor System</intervention_name>
    <description>glucose monitoring</description>
    <arm_group_label>Blinded</arm_group_label>
    <arm_group_label>Unblinded</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 Diabetes

          -  18 years or older

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Current pregnancy or anticipation of pregnancy during study period

          -  At screening visit, HR&gt; 130 or SBP&gt;160 or DBP&gt;100 which remains present on recheck
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

